|
|
|
Volumn 18, Issue 2, 1997, Pages 69-72
|
|
Phase III clinical trial on meisoindico in the treatment of chronic myelogenous leukemia
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
RECURRENT DISEASE;
TIME;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
FEMALE;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MALE;
MIDDLE AGED;
RECURRENCE;
TIME FACTORS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 0003193707
PISSN: 02532727
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|